Free Republic

Regeneron Pharmaceuticals has announced a plan to acquire the bankrupt genetic testing company 23andMe for $256 million, raising privacy concerns as the pharmaceutical giant will gain access to the genetic data of over 15 million customers. The New York Post reports that Regeneron Pharmaceuticals has seized the opportunity to acquire the once-thriving genetic testing company 23andMe, which recently filed for bankruptcy. The $256 million deal will grant Regeneron access to 23andMe’s extensive collection of genetic samples and data, encompassing the personal information of more than 15 million customers. This acquisition has raised significant concerns among privacy advocates and customers who...

Millions just witnessed the end of a presidency live on television. Joe Biden’s performance during the debate was embarrassing. Whenever CNN put him up on the split screen, he had a thousand-yard stare. He didn’t look old. He looked ancient. He looked empty. But at least he wasn’t speaking. Because when it was his time to answer, Biden was incoherent. He said he “beat Medicaid.” Asked about abortion, he randomly started talking about migrant crime. “I really don’t know what he said at the end of that sentence,” former President Trump noted at one point, “and I don’t think he...